This view is supported by studies showing defective suppressor function in CD4+CD25+ T cells from T1D patients [43], [44] and by studies showing that Foxp3 mRNA expression (relative to the number of Foxp3+ Tregs) is reduced in patients with potential CD or T1D [45], [46]. The gene discussed is FOXP3; the disease is type 1 diabetes mellitus.